Doxapram is a promising new antiarrhythmic drug for an atrial-specific therapy of atrial fibrillation
31 August 2019 (00:00 - 00:00)
Organised by:
About the speaker
University Medical Centre of Gottingen (UMG), Goettingen (Germany)
5 More presentations in this session
Mrs M. Jacobs (Groningen, NL)
Mr L. Iden (Bad Segeberg, DE)
Doctor J. Carmo (Carnaxide, PT)
Doctor M. Jan (Ljubljana, SI)
Doctor A. Verma (Montreal, CA)
Access the full session
The Event
ESC Congress 2019
31 August - 4 September 2019
You may be interested in
Congress Session
Congress Presentation
Congress Presentation
